Hans C. Ablij

599 total citations
9 papers, 421 citations indexed

About

Hans C. Ablij is a scholar working on Epidemiology, Pediatrics, Perinatology and Child Health and Urology. According to data from OpenAlex, Hans C. Ablij has authored 9 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Pediatrics, Perinatology and Child Health and 2 papers in Urology. Recurrent topics in Hans C. Ablij's work include Urinary Tract Infections Management (9 papers), Pediatric Urology and Nephrology Studies (6 papers) and Urinary Bladder and Prostate Research (2 papers). Hans C. Ablij is often cited by papers focused on Urinary Tract Infections Management (9 papers), Pediatric Urology and Nephrology Studies (6 papers) and Urinary Bladder and Prostate Research (2 papers). Hans C. Ablij collaborates with scholars based in Netherlands, Germany and Qatar. Hans C. Ablij's co-authors include Nathalie M. Delfos, Ted Koster, Jaap T. van Dissel, Cees van Nieuwkoop, J. W. van’t Wout, Eliane M.S. Leyten, Martin Becker, Geert H. Groeneveld, Tobias Bonten and Jeanet W. Blom and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and Critical Care.

In The Last Decade

Hans C. Ablij

9 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans C. Ablij Netherlands	9	355	134	72	69	56	9	421
Nathalie M. Delfos Netherlands	12	410 1.2×	146 1.1×	84 1.2×	85 1.2×	70 1.3×	23	532
Deborah Church United States	8	501 1.4×	224 1.7×	58 0.8×	179 2.6×	67 1.2×	8	661
Tanya Babich Israel	8	258 0.7×	75 0.6×	43 0.6×	58 0.8×	40 0.7×	20	315
George Koratzanis Greece	10	198 0.6×	29 0.2×	36 0.5×	48 0.7×	31 0.6×	14	343
Deepak Batura United Kingdom	12	223 0.6×	64 0.5×	53 0.7×	99 1.4×	85 1.5×	43	528
José Miguel Nogueira Spain	9	222 0.6×	45 0.3×	52 0.7×	19 0.3×	31 0.6×	17	309
G K Harding Canada	10	214 0.6×	59 0.4×	31 0.4×	83 1.2×	60 1.1×	12	332
Anders Lannergård Sweden	10	221 0.6×	45 0.3×	47 0.7×	25 0.4×	18 0.3×	18	363
Monique Crowley United States	9	236 0.7×	62 0.5×	32 0.4×	96 1.4×	71 1.3×	13	319
Seung-Kwan Lim South Korea	11	184 0.5×	70 0.5×	28 0.4×	35 0.5×	21 0.4×	18	333

Countries citing papers authored by Hans C. Ablij

Since Specialization

Citations

This map shows the geographic impact of Hans C. Ablij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans C. Ablij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans C. Ablij more than expected).

Fields of papers citing papers by Hans C. Ablij

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans C. Ablij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans C. Ablij. The network helps show where Hans C. Ablij may publish in the future.

Co-authorship network of co-authors of Hans C. Ablij

This figure shows the co-authorship network connecting the top 25 collaborators of Hans C. Ablij. A scholar is included among the top collaborators of Hans C. Ablij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans C. Ablij. Hans C. Ablij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Stalenhoef, Janneke E., Cees van Nieuwkoop, Darius Cameron Wilson, et al.. (2019). Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection. BMC Infectious Diseases. 19(1). 161–161. 15 indexed citations

Stalenhoef, Janneke E., Cees van Nieuwkoop, Darius Cameron Wilson, et al.. (2018). Biomarker guided triage can reduce hospitalization rate in community acquired febrile urinary tract infection. Journal of Infection. 77(1). 18–24. 17 indexed citations

Nieuwkoop, Cees van, Janneke E. Stalenhoef, T. J. K. van der Reijden, et al.. (2017). Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women. BMC Medicine. 15(1). 70–70. 54 indexed citations

Stalenhoef, Janneke E., Albert M. Vollaard, Ewout W. Steyerberg, et al.. (2017). Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule. BMC Infectious Diseases. 17(1). 400–400. 11 indexed citations

Vollaard, Albert M., Cees van Nieuwkoop, Janneke E. Stalenhoef, et al.. (2014). Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection. Clinical Microbiology and Infection. 20(10). 1048–1054. 36 indexed citations

Nieuwkoop, Cees van, Tobias Bonten, J. W. van’t Wout, et al.. (2010). Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Critical Care. 14(6). 140 indexed citations

Nieuwkoop, Cees van, Tobias Bonten, J. W. van’t Wout, et al.. (2010). Predicting the Need for Radiologic Imaging in Adults with Febrile Urinary Tract Infection. Clinical Infectious Diseases. 51(11). 1266–1272. 44 indexed citations

Nieuwkoop, Cees van, S. Paltansing, J. W. van’t Wout, et al.. (2010). Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection. Journal of Antimicrobial Chemotherapy. 66(3). 650–656. 92 indexed citations

Nieuwkoop, Cees van, J. W. van’t Wout, Willem JJ Assendelft, et al.. (2009). Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days). BMC Infectious Diseases. 9(1). 131–131. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact